ROCO
4138
Market cap47mUSD
Jul 09, Last price
50.90TWD
1D
-0.59%
1Q
-18.56%
Jan 2017
15.13%
IPO
6.20%
Name
Dynamic Medical Technologies Inc
Chart & Performance
P/E
10.04
P/S
1.10
EPS
5.07
Div Yield, %
8.15%
Shrs. gr., 5y
7.30%
Rev. gr., 5y
6.56%
Revenues
1.39b
-11.82%
Net income
152m
-25.97%
CFO
310m
+38.19%
Dividend
Apr 18, 20254.565 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dynamic Medical Technologies Inc., encompassing its various subsidiaries, operates within the aesthetic industry throughout Taiwan and Hong Kong. The company's primary focus involves the commercialization and upkeep of cosmetic laser and light-based equipment. Its extensive product range, which it both distributes and sells, includes specialized aesthetic medical instruments, body sculpting technologies, injectable dermal fillers, and high-grade cosmeceuticals, alongside a diverse selection of beauty treatment and cosmetic items. Additionally, Dynamic Medical Technologies delivers professional services such as training for aestheticians and consultation for clinical operational efficiency. The company is organized into distinct segments: Dynamic, Hong Kong Dynamic, Excelsior Beauty, and CYJ. Established in 1992, its main operational hub is situated in New Taipei City, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||